Published in Hospital Business Week, May 16th, 2004
Authors of the Journal of the American Medical Association (JAMA) article also confirmed the established risk of stroke for women taking the dosage studied in the WHI. By quantifying this known risk more clearly, this study will help women and their healthcare providers individualize therapy for vasomotor symptoms and osteoporosis prevention, given their own risk/benefit profiles.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.